129 related articles for article (PubMed ID: 9223425)
21. Signal transduction for proteinase-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells.
Kawao N; Nagataki M; Nagasawa K; Kubo S; Cushing K; Wada T; Sekiguchi F; Ichida S; Hollenberg MD; MacNaughton WK; Nishikawa H; Kawabata A
J Pharmacol Exp Ther; 2005 Nov; 315(2):576-89. PubMed ID: 16120814
[TBL] [Abstract][Full Text] [Related]
22. Activation of extracellular signal-regulated kinase in human prostate cancer.
Price DT; Della Rocca G; Guo C; Ballo MS; Schwinn DA; Luttrell LM
J Urol; 1999 Oct; 162(4):1537-42. PubMed ID: 10492251
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
24. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma.
Schuierer MM; Bataille F; Weiss TS; Hellerbrand C; Bosserhoff AK
Oncol Rep; 2006 Sep; 16(3):451-6. PubMed ID: 16865242
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
26. GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells.
Andrieux LO; Fautrel A; Bessard A; Guillouzo A; Baffet G; Langouët S
Cancer Res; 2007 Mar; 67(5):2114-23. PubMed ID: 17332341
[TBL] [Abstract][Full Text] [Related]
27. Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx.
Garavello W; Nicolini G; Aguzzi A; Maggioni D; Leone BE; Viganò P; Gaini RM; Tredici G
Oncol Rep; 2006 Sep; 16(3):479-84. PubMed ID: 16865246
[TBL] [Abstract][Full Text] [Related]
28. Making the connection: coupling of stress-activated ERK/MAPK (extracellular-signal-regulated kinase/mitogen-activated protein kinase) core signalling modules to extracellular stimuli and biological responses.
Kyriakis JM
Biochem Soc Symp; 1999; 64():29-48. PubMed ID: 10207619
[TBL] [Abstract][Full Text] [Related]
29. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
30. [Expression of mitogen-activated protein kinase and its upstream regulated signal in human hepatocellular carcinoma].
Zhu J; Leng X; Dong N; Liu Y; Li G; Du R
Zhonghua Wai Ke Za Zhi; 2002 Jan; 40(1):1-16. PubMed ID: 11955369
[TBL] [Abstract][Full Text] [Related]
31. Mitogen-activated protein kinases in hepatocellular carcinoma development.
Min L; He B; Hui L
Semin Cancer Biol; 2011 Feb; 21(1):10-20. PubMed ID: 20969960
[TBL] [Abstract][Full Text] [Related]
32. Decreased MAP kinase activity in human gastric adenocarcinoma.
Atten MJ; Attar BM; Holian O
Biochem Biophys Res Commun; 1995 Jul; 212(3):1001-6. PubMed ID: 7626085
[TBL] [Abstract][Full Text] [Related]
33. MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity.
Attar BM; Atten MJ; Holian O
Anticancer Res; 1996; 16(1):395-9. PubMed ID: 8615643
[TBL] [Abstract][Full Text] [Related]
34. [Protein kinases and phospholipids in human hepatocellular carcinoma].
Liu Y
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):242-4. PubMed ID: 1666869
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory guanine nucleotide regulatory protein activation of mitogen-activated protein kinase in experimental hepatocellular carcinoma in vitro.
McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):761-8. PubMed ID: 10445797
[TBL] [Abstract][Full Text] [Related]
36. Increased activity and expression of MAP kinase in HCC model rats induced by 3'-methyl-4-dimethylamino-azobenzene.
Toyoda M; Hashimoto N; Tokita K; Goldstein BJ; Yokosuka O; Kanatsuka A; Suzuki Y; Saito Y
J Hepatol; 1999 Oct; 31(4):725-33. PubMed ID: 10551398
[TBL] [Abstract][Full Text] [Related]
37. Enhanced expression and activation of Ca(2+)/calmodulin-dependent protein kinase IV in hepatocellular carcinoma.
Tamura N; Tai Y; Sugimoto K; Kobayashi R; Konishi R; Nishioka M; Masaki T; Nagahata S; Tokuda M
Cancer; 2000 Nov; 89(9):1910-6. PubMed ID: 11064347
[TBL] [Abstract][Full Text] [Related]
38. Comparison of membrane-associated proteins in human cholangiocarcinoma and hepatocellular carcinoma cell lines.
Srisomsap C; Subhasitanont P; Sawangareetrakul P; Chokchaichamnankit D; Ngiwsara L; Chiablaem K; Svasti J
Proteomics Clin Appl; 2007 Jan; 1(1):89-106. PubMed ID: 21136613
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma.
Hwang YH; Choi JY; Kim S; Chung ES; Kim T; Koh SS; Lee B; Bae SH; Kim J; Park YM
Hepatol Res; 2004 Jun; 29(2):113-121. PubMed ID: 15163433
[TBL] [Abstract][Full Text] [Related]
40. MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma.
Moon H; Ro SW
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34204242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
